Fox 19: Drivers failing to report health conditions to BMV could put others at risk
In 2022, 865 out of nearly 3.5 million people applying or renewing their driver's license in Ohio self-reported medical issues to the Ohio Bureau of Motor Vehicles (BMV).
BMV officials say that number is too low, as people not reporting their medical issues can lead to medical-related crashes that lead to injuries and deaths.
The University of Cincinnati's David Ficker, MD, told Fox 19 he knows of numerous epilepsy patients who were involved in a seizure-related crash.
“Particularly, if you’re looking just at epilepsy and the prevalence of epilepsy, 1%-2% of the population, that translates into a much higher number of patients that should be reporting to the BMV that they’ve had this history of seizures or epilepsy,” said Ficker, professor in the Department of Neurology and Rehabilitation Medicine in UC’s College of Medicine and a UC Health physician at the UC Gardner Neuroscience Institute.
Ficker said if he recommends a driver stay off the road and he does not feel they will listen, there is an avenue for him to report that driver to the state, but he needs the patient to sign off so he can discuss their medical issues with the Ohio BMV.
Featured photo at top of person with their hand on a steering wheel. Photo/Peter Kalonji/iStock.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.